Brittany Hall
Medical · Baton Rouge, LANPI 1568759710
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 358 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by AbbVie at 27.9% of the total. Among medical clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 358 payments — averaging $16.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$685
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$583
- Bristol Myers Squibb$495
- Takeda Pharmaceuticals U.S.A., Inc.$432
- Madrigal Pharmaceuticals$186
- plus $2K from 25 others
What the payments were for
- Food & beverage$5,761100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,761 in reported general payments places this provider in the 90th percentile of 253 medical providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 207 | $174,180 |
| XifaxanRifaximin | 31 | $52,214 |
| CreonLipase/Protease/Amylase | 17 | $25,052 |
| Lubiprostone | 88 | $9,471 |
| Pantoprazole Sodium | 680 | $9,406 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 47 | $7,628 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 98 | $6,933 |
| Dexlansoprazole DrDexlansoprazole | 19 | $6,067 |
| Colestipol Hcl | 67 | $5,537 |
| Omeprazole | 238 | $4,810 |
| PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C | 29 | $3,964 |
| SuflavePeg 3350/Sod Sulf,chlr/Pot/Mag | 29 | $3,444 |
| Famotidine | 171 | $3,176 |
| Dicyclomine Hcl | 146 | $2,914 |
| Esomeprazole Magnesium | 72 | $2,650 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess, Creon | $1,608 | $199,232224 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Plenvu | $583 | $56,17860 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $47 | $7,62847 claims |
| Braintree Laboratories, Inc.Suflave | $67 | $3,44429 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 253 medical providers in Louisiana.
Other medical in Baton Rouge
- Kristi RobertBaton Rouge$486K
- Vickie RiceBaton Rouge$19K
- Emily FerraraBaton Rouge$9K
- Karla GorioBaton Rouge$9K
- Kimberly BergeronBaton Rouge$7K
- Rebecca LandryBaton Rouge$5K
- Connie BrunsonBaton Rouge$5K
- Lindsay BrunsonBaton Rouge$5K
- Jessica TempletBaton Rouge$5K
- Brooke VincentBaton Rouge$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.